S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

ITOS iTeos Therapeutics Inc

11.66

0.17 (1.48%)

After Hours

Last Updated: 08:06:43

Delayed by 15 minutes

iTeos Therapeutics reports Q3 results

To read the full story on Seeking Alpha, click here.

iTeos Therapeutics (NASDAQ:ITOS)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more iTeos Therapeutics Charts.

iTeos Therapeutics (NASDAQ:ITOS)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more iTeos Therapeutics Charts.

iTeos Therapeutics Inc News

iTeos Presents EOS-984 Preclinical Data Demonstrating Restoration of T Cell Activity from Adenosine Suppression at the American Association for Cancer Research Annual Meeting 2024
Monday 8 April 2024 (4 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 9 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 9 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 9 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 9 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

iTeos Appoints Oncology Veteran Jill DeSimone to Its Board of Directors
Wednesday 6 March 2024 (2 months ago) • GlobeNewswire Inc.

iTeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
Wednesday 6 March 2024 (2 months ago) • GlobeNewswire Inc.

iTeos to Highlight Preclinical Data on First-In-Class EOS-984 Targeting ENT1 at the American Association for Cancer Research Annual Meeting 2024
Wednesday 6 March 2024 (2 months ago) • GlobeNewswire Inc.

More iTeos Therapeutics Inc News Articles

Australia And New Zealan...

S&P ASX 300 Metals and M...

AUD vs US Dollar

JP Morgan Chase

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions